(Q35946030)

11 August 2017

1 reference

title

Biomarkers of neurodegenerative disorders: how good are they? (English)

1 reference

11 August 2017

0 references

1 reference

Varun Rachakonda

1

1 reference

11 August 2017

Tian Hong Pan

series ordinal

2

1 reference

11 August 2017

Wei Dong LE

series ordinal

3

1 reference

11 August 2017

publication date

1 October 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

14

1 reference

11 August 2017

issue

5

1 reference

11 August 2017

page(s)

347-358

1 reference

Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons.

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Genetic and biochemical markers for Alzheimer's disease: recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Aggregation and neurotoxicity of alpha-synuclein and related peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Tau paired helical filaments from Alzheimer's disease brain and assembled in vitro are based on beta-structure in the core domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Early onset familial Alzheimer's disease: Mutation frequency in 31 families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed early-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Atypical dementia associated with a novel presenilin-2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Advances in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Parkinson's disease: piecing together a genetic jigsaw

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Mapping of a gene for Parkinson's disease to chromosome 4q21-q23

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

alpha-Synuclein locus triplication causes Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Significant linkage of Parkinson disease to chromosome 2q36-37

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

The ubiquitin pathway in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

The 1.1-A resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Mutations in NR4A2 associated with familial Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Biomarkers and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Effects of cerebrospinal fluid from patients with Parkinson disease on dopaminergic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

D90A-SOD1 mediated amyotrophic lateral sclerosis: a single founder for all cases with evidence for a Cis-acting disease modifier in the recessive haplotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Imaging and neurochemical markers for diagnosis and disease progression in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Alternative splicing of the 5'-sequences of the mouse EAAT2 glutamate transporter and expression in a transgenic model for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Reanalysis of multislice (1)H MRSI in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Recent advances in understanding the pathogenesis of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Genetically confirmed clinical Huntington's disease with no observable cell loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Single photon emission computerized tomography (SPECT) in detecting neurodegeneration in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

PARK6-linked parkinsonism occurs in several European families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

Stem cells in brain plasticity and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

Altered glycosylation of cerebrospinal fluid butyrylcholinesterase in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

The genetic defect causing familial Alzheimer's disease maps on chromosome 21.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of A beta 42(43)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

Amyloid precursor protein associates with a nicastrin-dependent docking site on the presenilin 1-gamma-secretase complex in cells demonstrated by fluorescence lifetime imaging.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

Splicing mutation of presenilin-1 gene for early-onset familial Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

2-Dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tools in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

In vivo amyloid imaging in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

CSF markers for Alzheimer's disease: Total tau, phospho-tau and Aβ42

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

CSF markers for pathogenic processes in Alzheimer's disease: diagnostic implications and use in clinical neurochemistry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

Serum melanotransferrin, p97 as a biochemical marker of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

p97 as a biomarker for Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

Expression of melanotransferrin isoforms in human serum: relevance to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

Clinical features and neuroimaging of PARK7-linked parkinsonism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

Pathological properties of the Parkinson's disease-associated protein DJ-1 in alpha-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

Mutant genes responsible for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Parkinson Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

Neuropathological spectrum of synucleinopathies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

A novel locus for familial amyotrophic lateral sclerosis, on chromosome 18q

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

Genetics of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

Mutation screening of the ALS2 gene in sporadic and familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

Amyotrophic lateral sclerosis: progress and prospects for treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

Magnetic resonance imaging and magnetic resonance spectroscopy in dementias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290235

7 January 2021

Identifiers

DOI

10.1038/SJ.CR.7290235

1 reference

11 August 2017

1 reference